ACN Newswire (press release) In addition, 3 products have been listed in the State Torch Program. Furthermore, the Company obtained the manufacturing approval for ambroxol hydrochloride injection, a new respiratory drug developed by the Company, which will be made available to the ... and more »
PharmaTimes The cancer drug Taxotere ( docetaxel ) slumped 17.3% to 108 million euros, while Lovenox fell 18.6% to 428 million euros. Eloxatin sales crashed 84.6% to 59 million euros. On the bright side, the diabetes drug Lantus (insulin glargine) leapt 19.7% to 1 ... and more »
